Webinar: Accelerating Lead Identification Through Integrated Antibody Development and Characterization Workflows

Watch our webinar on demand to discover how lead identification can be accelerated through optimized, integrated antibody and biotherapeutic development and characterization workflows.

Dr. Matt Heidtman demonstrates a scalable workflow to express and purify ~100 recombinant antibodies in a single run, addressing common bottlenecks in large‑scale screening campaigns.

Dr. Jessica Fiege highlights an improved approach to CHO‑K1 cell line development using the TcBuster® transposon system, delivering significantly higher antibody titers and more productive clones than traditional random integration.

Finally, Dr. Srinivasa Rao showcases rapid, high‑resolution biophysical methods using icIEF and CE-SDS techniques on the Maurice system to assess size, purity, and charge heterogeneity—critical quality attributes that enable confident lead selection early in development.

Together, these strategies provide an integrated path from antibody discovery to developable, manufacturable candidates—faster and with greater confidence.